| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/24/2009 | US7494787 diploid yeast strain; virus-like particle (VLP) comprising a first late 1 (L1) capsid protein from human papilloma virus (HPV) type 6 and a second L1 capsid protein from HPV type 16; Saccharomyces cerevisiae |
| 02/24/2009 | US7494786 Genetically engineered nuclear inclusion proteinase (NIa) comprising increased stability for obtaining large quantities of purified active proteins that form inclusion bodies in cells; modifying enzyme for premature polypeptides |
| 02/24/2009 | US7494785 Recombinant subunit vaccine |
| 02/24/2009 | US7494782 Assay for measuring factor viia-antithrombin complexes |
| 02/24/2009 | US7494779 Method for producing human antibodies to human CD152 with properties of agonist, antagonist, or inverse agonist |
| 02/24/2009 | US7494775 Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer |
| 02/24/2009 | US7494774 Assay and compositions for detection of Bacillus anthracis nucleic acid |
| 02/24/2009 | US7494767 Assay for TSG101 as inhibitors of HIV production |
| 02/24/2009 | US7494653 Inoculating a patient with an effective amount of PcrV antigen; monoclonal antibodies specific for the PcrV antigen |
| 02/24/2009 | US7494650 Monoclonal antibodies to hepatocyte growth factor |
| 02/24/2009 | US7494647 Chimeric immunoglobulin for prevention and treatment blood, tumor, cardiovascular and urogenital disorders |
| 02/24/2009 | US7494645 proteins comprising an amino acid sequence including the catalytic region and regulatory domains; the protein inhibits neurite retraction in an (lysophosphatidic acid) LPA-induced neurite retraction bioassay; used for treating nervous system disorders and/or injuries |
| 02/24/2009 | US7494644 contacting a myocardial cells with genetic engineered mammalian cells modified to express a connexin 43 proteins, to establishing electrical coupling between cardiomyocytes and recombinant cells; treatment of cardiac disease or tissue repair |
| 02/24/2009 | CA2414978C Preparation of a recombinant protein in a prokaryotic host cell |
| 02/24/2009 | CA2249061C Protein production process |
| 02/24/2009 | CA2214633C Antibody purification by low-ph hydrophobic interaction chromatography |
| 02/24/2009 | CA2179029C Vertebrate embryonic pattern-inducing hedgehog-like proteins |
| 02/19/2009 | WO2009023816A1 Methods of making monoclonal antibodies using fusion- peptide epitope adoptive transfer (f-peat) technology |
| 02/19/2009 | WO2009023760A1 Novel methods and cell lines |
| 02/19/2009 | WO2009023562A2 Use of perfusion to enhance production of fed-batch cell culture in bioreactors |
| 02/19/2009 | WO2009023270A2 Compositions and methods for modifying properties of biologically active polypeptides |
| 02/19/2009 | WO2009022900A2 A process to produce polypeptides from soybean |
| 02/19/2009 | WO2009022656A1 Recombinant mammalian cells, method of producing recombinant mammalian cells and method of producing target protein |
| 02/19/2009 | WO2009022162A1 Bacillus with inactivated or downregulated htra and/or htrb |
| 02/19/2009 | WO2009021853A1 Eukaryotic promoters for gene expression |
| 02/19/2009 | WO2009021448A1 A plant height regulatory gene and uses thereof |
| 02/19/2009 | WO2008106694A3 Systems, methods and compositions for optical stimulation of target cells |
| 02/19/2009 | WO2008094200A8 Chimeric virus-like particles |
| 02/19/2009 | WO2006052914A3 Diacylglycerol acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms |
| 02/19/2009 | US20090048434 Compositions and methods relating to orthogonal ribosome mRNA pairs |
| 02/19/2009 | US20090048431 Multivalent clostridial toxins |
| 02/19/2009 | US20090048169 Identification of Crmp4 as a Convergent Regulator of Axon Outgrowth Inhibition |
| 02/19/2009 | US20090048136 Kappa-carrageenase and kappa-carrageenase-containing compositions |
| 02/19/2009 | US20090048122 Stabilized polypeptide compositions |
| 02/19/2009 | US20090047711 Bis-sulfhydryl macrocyclization systems |
| 02/19/2009 | US20090047710 ST3Gal-1/ST6GalNAc-1 Chimeras |
| 02/19/2009 | US20090047709 Novel endoribonuclease |
| 02/19/2009 | US20090047708 Highly productive recombinant yeast strains with modified galactose-regulated transcription |
| 02/19/2009 | US20090047707 Bacterial recombinant phytase |
| 02/19/2009 | US20090047706 Process for producing dipeptides |
| 02/19/2009 | US20090047705 Microorganism-derived psychrophilic endonuclease |
| 02/19/2009 | US20090047387 Protease variants |
| 02/19/2009 | US20090047339 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 02/19/2009 | US20090047302 Chimaeric Human Papillomavirus 16 L1 Virus Like Particles and a Method for Preparing the Particles |
| 02/19/2009 | US20090047289 Osteopontin Specific Antibodies and Methods of Use Thereof |
| 02/19/2009 | US20090047283 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 02/19/2009 | US20090047273 Method For Production of Recombinant Human Thrombin ['644] |
| 02/19/2009 | US20090047217 Polynucleotides Encoding Members of the Human B Lymphocyte Activation Antigen B7 Family and Polypeptides Encoded Thereby |
| 02/19/2009 | CA2695929A1 A plant height regulatory gene and uses thereof |
| 02/19/2009 | CA2695374A1 Compositions and methods for modifying properties of biologically active polypeptides |
| 02/18/2009 | EP2025754A2 Moraxella (Branhamella) catarrhalis antigens |
| 02/18/2009 | EP2025753A2 Phagemid for screening antibodies |
| 02/18/2009 | EP2025749A1 Humanized anti-human osteopontin antibody |
| 02/18/2009 | EP2025682A2 Human endokine alpha |
| 02/18/2009 | EP2025235A1 Use of globular protein - oligosaccharide conjugates |
| 02/18/2009 | EP2024507A2 Fusion proteins, uses thereof and processes for producing same |
| 02/18/2009 | EP1831385A4 Enzymes for starch processing |
| 02/18/2009 | EP1799234A4 Enhancing recombinant hemoglobin production by co-expression with alpha hemoglobin stabilizing protein |
| 02/18/2009 | EP1562630A4 Injectible bioadhesive polymeric hydrogels as well as related methods of enzymatic preparation |
| 02/18/2009 | EP1555325B1 Novel fructosyl peptide oxidase and utilization thereof |
| 02/18/2009 | EP1405910B1 Process for producing human thrombin by gene modification technique |
| 02/18/2009 | EP1329503B1 Sphingolipid ceramide deacylase gene |
| 02/18/2009 | EP1196447B1 Method for stabilising proteins in complex mixtures during their storage in aqueous solvents |
| 02/18/2009 | EP1135467B1 Psca: prostate stem cell antigen and uses thereof |
| 02/18/2009 | EP1071955B2 Improved immunodiagnostic assays using reducing agents |
| 02/18/2009 | EP0941337B1 Synthesis and purification of hepatitis c virus-like particles |
| 02/18/2009 | EP0922761B1 Monoclonal antibody specific to anti-human fibrin monomer, process for producing the same, hybridomas, and immunoassay method |
| 02/18/2009 | EP0673415B1 Recombinant viral vector system |
| 02/18/2009 | CN101370819A Glucanases, nucleic acids encoding them and methods for making and using them |
| 02/18/2009 | CN101370516A Soluble fragments of the SARS-CoV spike glycoprotein |
| 02/18/2009 | CN101367877A Monkey monoclonal antibodies specific to human B7.1 and/or B7.2 primatized forms, pharmaceutical compositions |
| 02/18/2009 | CN101366737A Nano glossy ganoderma spore polypeptide product, preparation and application thereof |
| 02/18/2009 | CN100462443C Insect cell extract for synthesizing cell-free protein, preparation and application thereof |
| 02/18/2009 | CN100462442C Method for extracting protein from yellow rice wine stillage |
| 02/18/2009 | CN100462434C Novel alkaline protease variants and detergents containing these novel alkaline protease variants |
| 02/17/2009 | US7491867 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| 02/17/2009 | US7491809 Polynucleotides encoding human cytokine receptor |
| 02/17/2009 | US7491803 Atopic dermatitis, airway inflammation, airway hyperresponsiveness, or asthma; cytokine biosynthesis inhibition; diagnostic kits |
| 02/17/2009 | US7491801 Identification and development of specific monoclonal antibodies to squamous cell carcinoma |
| 02/17/2009 | US7491800 Cytokine zalpha11 ligand fusion proteins |
| 02/17/2009 | US7491798 Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins |
| 02/17/2009 | US7491539 Sequence specific DNA recombination in eukaryotic cells |
| 02/17/2009 | US7491529 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/17/2009 | US7491528 Method for extracellular production of target proteins employing OmpF in E. coli |
| 02/17/2009 | US7491521 Rhodococcus nitrile hydratase |
| 02/17/2009 | US7491520 by organism cell biosynthesis from 6-aminohex-2-enoic acid or transform 6-amino-2-hydroxy-hexanoic acid to 6-aminohex-2-enoic acid, in presence of an enzyme having alpha , beta -enoate reductase; chemical intermediates for nylon-6 production |
| 02/17/2009 | US7491516 Dual specificity antibodies and methods of making and using |
| 02/17/2009 | US7491515 Recombinant polypeptides for diagnosing infection with Trypanosoma cruzi |
| 02/17/2009 | US7491514 High specificity antibodies with reduce immunogenicity; evaluative and diagnostic tools; immunotherapy |
| 02/17/2009 | US7491513 Composition and method for treating lupus nephritis |
| 02/17/2009 | US7491512 recombinant production of polypeptides having sequence similarity to interleukin-17 and interleukin-17 receptor protein; from E. coli, or yeast cell; vectors, host cells; produce immunostimulants, immunosuppressants, agonists, antagonists, biodrugs |
| 02/17/2009 | US7491511 isolated nucleic acid encoding a fungal antigen from Candida albicans; antiallergenic reaction to fungi in a vertebrate; and diagnosing a disease caused by fungi in a vertebrate; desensitization therapy for vaccines; insoluble cytoplasmic membrane proteins, free of cell wall |
| 02/17/2009 | US7491510 Protein secretion in eukaryotic cells |
| 02/17/2009 | US7491509 Viral expression vector for transfer and expression of heterologous gene in plants; bioreactors |
| 02/17/2009 | US7491508 termini grow efficiently in desired cell line; left terminus spans the 5' inverted terminal repeat, left terminus spans the E4 region and the 3' inverted terminal repeat; internal regions does not grow efficiently in the desired cell; adenovirus vectors use for gene therapy; culturing; vaccines |
| 02/17/2009 | US7491507 Using lactobacillus to ferment hypotensive agents comprised of milk protein amino acid sequences; treatment for hypertension |
| 02/17/2009 | US7491405 Antigenic protein originating in Malassezia |
| 02/17/2009 | US7491401 Lawsonia intracellularis vaccine |
| 02/17/2009 | US7491398 Proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 02/17/2009 | US7491392 An isolated IL-1 beta binding molecule comprising a heavy chain variable domain; treatment of an IL-1 mediated disease or disorder, e.g. osteoarthritis, osteroporosis and other inflammatory arthritis |